The Braff Group Advises IV Solutions, LLC in its Sale to Singlepoint Healthcare

Singlepoint Healthcare, a portfolio of DFW Capital Partners announced last week the acquisition of IV Solutions, LLC(IVS), a leading provider of clinical pharmacy and home infusion services inWood Dale, Ill.This acquisition helps establish a strong foundation for Singlepoint's integrated model and provide access to critical expertise in both clinical care and pharmaceutical services. https://mma.prnewswire.com/media/2264066/TheBraffGroup_Logo.jpg The […]

Patrick Higgins Named Chief Revenue Officer at Robots & Pencils

From IBM transformation to AI-powered product strategy, Higgins brings proven enterprise expertise and client-first vision to fuel the firm's next phase of commercial expansion Robots & Pencils, an AI-first, global digital innovation firm specializing in cloud-native web, mobile, and app modernization, today announced the appointment of Patrick Higgins as Chief Revenue Officer (CRO). A seasoned

WestJet and RBC introduce the WestJet RBC® World Elite Mastercard‡ for Business

WestJet and RBC today announced the launch of the WestJet RBC® World Elite Mastercard‡ for Business, Canada's first and only business travel credit card that instantly provides primary cardholders with top-tier airline status. This business credit card promptly awards primary cardholders Silver status* with WestJet Rewards, offering them the fastest way to earn WestJet points

Citizen Health Raises $30 Million to Build AI Advocate for Every Patient, Ushering in a New Era of Patient-Centered Healthcare

Citizen Health, a patient-powered platform transforming rare disease care, announced today it has raised $30 million in Series A funding. The round was led by 8VC, with participation from Transformation Capital and Headline, bringing the company's total funding to $44 million since its December 2023 launch. https://mma.prnewswire.com/media/2561329/666c5fefe81949e4f54d7a9b_citizen_logo_Logo.jpg Founded by Farid Vij (CEO & Co-founder), Nasha

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fortrea Holdings, Inc. (FTRE) And Encourages Stockholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fortrea Holdings, Inc. ("Fortrea" or "the Company") (NASDAQ:FTRE). Investors who purchased Fortrea securities prior to July 3, 2023, and continue to hold to the present, are encouraged to obtain

Elevance Health, Inc. (ELV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV). Investors who purchased Elevance securities prior to April 18, 2024, and continue to hold to the present, are encouraged to obtain

Medical Solutions CEO Rebecca Rogers Tijerino named among inaugural 2025 Nashville Titan 100 honorees

Medical SolutionsCEO Rebecca Rogers Tijerinohas been recognized as one of the 2025 Nashville Titan 100, an inaugural list honoring the region's top CEOs and C-level executives for exceptional leadership, vision, and impact. https://mma.prnewswire.com/media/1983199/Medical_Solutions_Logo.jpg Tijerino joins a distinguished group of leaders who represent diverse industries, including healthcare, financial services, technology, real estate, and non-profits. “The inaugural

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nextracker Inc. (NXT) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nextracker Inc. ("Nextracker" or "the Company") (NASDAQ:NXT). Investors who purchased Nextracker securities prior to February 1, 2024, and continue to hold to the present, are encouraged to obtain additional

Bronstein, Gewirtz & Grossman, LLC Encourages Evolv Technologies Holdings, Inc. (EVLV) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Evolv Technologies Holdings, Inc. ("Evolv Technologies" or "the Company") (NASDAQ:EVLV). Investors who purchased Evolv Technologies securities prior to August 19, 2022, and continue to hold to the present, are

Scroll to Top